Skip to content

Androgen insensitivity syndrome




Endocrine system

Adrenal gland disorders
Thyroid gland disorders
Parathyroid gland disorders
Pancreatic disorders
Pituitary gland disorders
Gonadal dysfunction
Polyglandular syndromes
Endocrine tumors
Endocrine system pathology review

Androgen insensitivity syndrome


0 / 9 complete


1 / 3 complete
High Yield Notes
9 pages

Androgen insensitivity syndrome

9 flashcards

USMLE® Step 1 style questions USMLE

3 questions

USMLE® Step 2 style questions USMLE

1 questions

A 20-year-old woman comes to the office because she has not had her first menstrual period. Physical examination shows normal breast development, but minimal axillary and pubic hair. Pelvic examination shows that the vagina ends in a blind pouch, and masses are palpable in the inguinal region. Which of the following karyotype findings is most likely?

External References

Androgen insensitivity syndrome is a genetic disorder, in which a person with an XY genotype - genetically a male – is “insensitive” or doesn’t respond to androgens, which are male sex hormones.

Androgens are responsible for primary sex characteristics like development of the penis and testes as well as secondary sex characteristics like height and body shape, so in androgen insensitivity syndrome all of these can be affected.

Okay, normally, very early on in fetal life, male and female genital tissues are undifferentiated and look identical.

During the 7th or 8th week, the fetal gonads develop either into testes or ovaries.

In males, a gene on the Y chromosome, called the sex-determining region Y gene, or SRY gene for short, helps the fetal gonads turn into the testes.

By the end of week 8, the testes start producing androgens, the main one being testosterone.

A small fraction of testosterone, gets converted by the enzyme 5α- reductase into its more potent form, called dihydrotestosterone, which is mostly responsible for development of male external genitalia.

Looking closely at these structures, at the top there’s the genital tubercle, which is a small projection.

Just below that, there's the urethral groove, which is the external opening of the urogenital sinus or the future urethra and bladder and is surrounded by the urethral folds and the labioscrotal swellings.

Now, once dihydrotestosterone reaches the undifferentiated external genital structures, it makes the genital tubercle elongate into the phallus that eventually becomes part of the penis.

The elongating genital tubercle pulls up the urethral folds which fuse in the midline, forming the spongy or penile urethra.

Only the tips of these folds remain unfused to form the external urethral opening at the distal part of the penis.

The labioscrotal swellings also grow toward each other fuse medially to form the scrotum, which is the sac skin that contain the testes.

Internally, the urogenital sinus is connected to a set of ducts, called Wolffian and Mullerian ducts.

Testosterone also causes the Wolffian ducts to differentiate into the epididymis, vas deferens, and seminal vesicles.

At the same time, the testes also produce a hormone called anti-Müllerian hormone which prevents the Müllerian ducts from developing into the female reproductive tract and instead makes them degenerate.

About two months before birth, testosterone helps the testes descend from the abdomen into the future scrotum and later on, in puberty, testosterone helps sperm cells mature - a process called spermatogenesis.

In females, there’s no Y chromosome so the SRY gene is absent.

As a result, ovaries develop from the internal gonads, and androgen levels remain relatively low, so the genital tubercle remains small, forming the clitoris and the urethral folds and labioscrotal swellings remain unfused or separate, forming inner and outer skin folds that surround the opening of the vagina and are called labia minora and labia majora.

Without the testes, anti- Müllerian hormone is also absent, so Müllerian ducts develop into the fallopian tubes, uterus, and upper part of the vagina.

In androgen insensitivity syndrome, XY-individuals have testes that produce androgens, but these hormones can’t exert their action, because there’s a defect in the androgen receptor on various target tissues like the external genitalia, genital ducts, and the testes itself.

Androgen insensitivity can be complete, partial, or mild, depending on how well the androgen receptor is able to bind androgens.

In complete androgen insensitivity, the receptor is totally nonfunctional, so the cells don’t respond to androgens at all. As a result, the testes tries to respond by increasing androgen synthesis.

Without the effects of androgens, the testes sometimes don’t descend into the scrotum and instead remain in the abdomen or pelvis, which is called cryptorchidism.

Androgen insensitivity syndrome is a condition that results in the partial or complete inability of cells to respond to androgens whose purpose is to bind to androgen receptors to stimulate or control the development and maintenance of male physiological characteristics. This unresponsiveness of cells to the presence of androgenic hormones can either impair or prevent both the masculinization of male genitalia in a developing fetus and the development of male secondary sexual characteristics at puberty. As such, androgen insensitivity syndrome is of clinical significance only when it occurs in individuals with a Y-chromosome.